Services: Health EconomicsMarket AccessHealth Technology AssessmentReal World EvidenceMedical writingBCN Database
Health economics models are important tools used in the decision-making process aimed at optimizing the use of available medical resources and healthcare budgets.
BCN HEALTH’s health economics team has wide experience in the development of economic modelling methods according to the guidelines requested by the HTA bodies in most therapeutic areas:
- Drugs, medical devices and diagnostic tools
- Cost-effectiveness, cost-utility, cost-consequence and cost minimisation modelling (decision tree, Markov model, Monte Carlo method)
- Budget impact models and economic burden of disease
- Quality of life studies: design and validation of new instruments, population studies
Literature review is conducted on the epidemiological and economic aspects in all diseases areas to obtain the parameters needed to populate models:
- Epidemiology, incidence, and prevalence estimations
- Estimations on the target populations sizes and profiles
- Estimations on the parameters and inputs
Market access services are really important in the Pricing and Reimbursement of new drugs. Market access services evolve within the technical and administrative framework of procedures and requirements laid by national jurisdictions.
BCN HEALTH’s market access team has wide experience in Pricing and Reimbursement, Pharmacovigilance and Clinical Research. We provide our expertise along the Pricing and Reimbursement process:
- Literature review and evidence research to generate product value messages
- Clinical and Pricing dossiers (registration, extension of indication, renewal of registration, re-evaluation)
- Value-added dossiers for public administrations
- Strategic guidance in Pricing and Reimbursement (products in development or already marketed)
- Post-submission support including response to formal evaluation reports
We also provide:
- Assistance in other dossiers submitted to local authorities: Hospital drugs and devices specific funding, retrocession, appraisal meetings
- Training in Pricing and Reimbursement issues
Health technology assessment is the systematic evaluation of the short- and long-term consequences (societal, economic, ethical, legal) of a health technology or drug, addressing the direct and intended effects of this technology, as well as its indirect and unintended consequences, and aimed mainly at informing decision making.
BCN HEALTH’s health technology assessment team has wide experience in reviewing previous positioning therapeutic reports and health technology reports of already approved and reimbursed health technologies or drugs for a specific indication.
BCN HEALTH’s real world evidence team has wide experience in analysing complex databases and in conducting statistical and observational studies.
BCN HEALTH has access to different databases:
- National hospital discharge and specialised care database
- National hospital, specialised and primary care database
BCN HEALTH also conducts observational studies to obtain patient data, to conduct patient preferences studies and to validate quality of life questionnaires.
To conduct the observational studies BCN HEALTH provides guidance in:
- Designing study documents
- CRF, e-CRF
- Protocol
- Data Handling Manual (DHM) and Statistical Analysis Plan (SAP)
- Data Management
- Descriptive statistical, comparative and multivariate analyses
- Writing of the statistical report
BCN HEALTH’s medical writing team has wide experience in writing and publishing more than 100 articles in both national and international peer reviewed journals.
BCN HEALTH has also experience in writing:
- Study protocols
- Technical reports
- Statistical reports
- Value dossiers
BCN HEALTH has 5 databases with relevant information in the field of health economics and market access. The information available includes cost tariffs, resources use and cost of different diseases, drug evaluation reports review, Spanish healthcare organisation and information about the Spanish regional commissions for drug evaluation.
- Resources used and cost of disease
This database includes information about different diseases for the total Spanish population, but also for each region.The information provided for each disease is:- Number of patients
- % of patients in each region
- Age
- Mortality
- Length of hospital stay
- Total cost
- Admission cost
- Cost per patient
- Comorbidities
- Costs tariffs and DRG
This database includes all the costs in the tariffs lists for each procedure or type of visit for each region and all the DRG costs available for Spain. - Healthcare organisation
This database contains all the information about each of the 17 health care systems in Spain. This database provides information about the health care systems structure and positions, with contact information for each position. - Regional commissions
This database contains all the information about all the regional commissions for drug evaluation in Spain, both for primary care and hospital care. This database provides information about the name of the commission, its function, composition, contact person and contact.
- Drug evaluation reports
This database contains all the information about all the regional and hospital drug evaluation reports and positioning therapeutic reports. The information for a specific disease includes all the drugs indicated for the disease. The parameters included in this database are:- Region
- Agency/Hospital
- Drug name
- Active ingredient
- Presentation
- Posology and administration form
- Authorization date AEMPS
- Pharmaceutical company
- Price
- Publication date
- Disease area
- Indication
- ATC code
- Study methodology
- Comparators
- Primary outcome measures
- Secondary outcome measures
- Efficacy measures
- Evaluation of secondary sources
- Adverse events
- Economic evaluation
- Treatment costs (drug and comparators)
- Conclusions
- Recommendations
